VOKANAMET

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, France, Ireland, Italy, Lithuania, Poland, Romania, Singapore, Spain, UK.

Active ingredients

The drug VOKANAMET contains a combination of these active pharmaceutical ingredients (APIs):

1	Canagliflozin UNII 0SAC974Z85 - CANAGLIFLOZIN
	Canagliflozin is an orally-active inhibitor of SGLT2. The SGLT2 transporter, expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. By inhibiting SGLT2, canagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose (RTG).
	Read more about Canagliflozin
2	Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VOKANAMET Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BD16	Metformin and canagliflozin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1645994, 1646007, 1646018, 1646029, 1646030, 1646041, 1646052, 1646063, 1646074, 1646085, 1646096, 1646108
ES	Centro de información online de medicamentos de la AEMPS	114918002, 114918005, 114918008, 114918011
FR	Base de données publique des médicaments	62635679, 63447178, 63706499, 66571380
GB	Medicines & Healthcare Products Regulatory Agency	280229, 280246
IE	Health Products Regulatory Authority	36955, 36956, 36957, 36958
IT	Agenzia del Farmaco	043375017, 043375029, 043375031, 043375043, 043375056, 043375068, 043375070, 043375082, 043375094, 043375106, 043375118, 043375120
LT	Valstybinė vaistų kontrolės tarnyba	1073204, 1073205, 1073206, 1073207, 1073208, 1073209, 1073210, 1073211, 1073212, 1073213, 1073214, 1073215
PL	Rejestru Produktów Leczniczych	100317679, 100317685, 100317691, 100317700
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W60975001, W60976001, W60977001, W60978001
SG	Health Sciences Authority	15797P, 15798P, 15799P, 15800P